These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35405115)

  • 61. Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes.
    Yoshio R; Taniguchi T; Itoh H; Muramatsu I
    Jpn J Pharmacol; 2001 Jun; 86(2):189-95. PubMed ID: 11459121
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stimulation frequency-noradrenaline release relationships examined in alpha2A-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
    Scheibner J; Trendelenburg AU; Hein L; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Oct; 364(4):321-8. PubMed ID: 11683519
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of postjunctional alpha-adrenoceptors in the pithed mouse.
    McCafferty GP; Naselsky DP; Hieble JP
    Gen Pharmacol; 1999 Jul; 33(1):99-105. PubMed ID: 10428022
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nomenclature and state of the art on alpha1-adrenoceptors.
    Langer SZ
    Eur Urol; 1998; 33 Suppl 2():2-6. PubMed ID: 9556189
    [TBL] [Abstract][Full Text] [Related]  

  • 65. α
    Sánchez-Soto M; Casadó-Anguera V; Yano H; Bender BJ; Cai NS; Moreno E; Canela EI; Cortés A; Meiler J; Casadó V; Ferré S
    Mol Neurobiol; 2018 Nov; 55(11):8438-8454. PubMed ID: 29552726
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The differential
    López-Córdoba G; Martínez-Lorenzana G; Lozano-Cuenca J; Condés-Lara M; González-Hernández A
    Front Pharmacol; 2022; 13():1023611. PubMed ID: 36506544
    [TBL] [Abstract][Full Text] [Related]  

  • 67. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
    Zhang W; Klimek V; Farley JT; Zhu MY; Ordway GA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1286-92. PubMed ID: 10336518
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification.
    MacKinnon AC; Kilpatrick AT; Kenny BA; Spedding M; Brown CM
    Br J Pharmacol; 1992 Aug; 106(4):1011-8. PubMed ID: 1327384
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor.
    Maïga A; Merlin J; Marcon E; Rouget C; Larregola M; Gilquin B; Fruchart-Gaillard C; Lajeunesse E; Marchetti C; Lorphelin A; Bellanger L; Summers RJ; Hutchinson DS; Evans BA; Servent D; Gilles N
    PLoS One; 2013; 8(7):e68841. PubMed ID: 23935897
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of desipramine on prazosin potency at α1A- and α1D-adrenoceptors in rat vas deferens: implications for the α1L-adrenoceptor subclassification.
    Docherty JR
    Eur J Pharmacol; 2014 Dec; 744():183-9. PubMed ID: 25446564
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional studies on alpha 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle.
    Michel MC; Hanft G; Gross G
    Br J Pharmacol; 1994 Feb; 111(2):539-46. PubMed ID: 7911719
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes.
    Amphoux A; Millan MJ; Cordi A; Bönisch H; Vialou V; Mannoury la Cour C; Dupuis DS; Giros B; Gautron S
    Eur J Pharmacol; 2010 May; 634(1-3):1-9. PubMed ID: 20170649
    [TBL] [Abstract][Full Text] [Related]  

  • 74. D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype.
    Sallinen J; Haapalinna A; Viitamaa T; Kobilka BK; Scheinin M
    Neuroscience; 1998 Oct; 86(3):959-65. PubMed ID: 9692731
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca(2+) changes: evidence for cross-talk between recombinant alpha(2A)- and native alpha(1)-adrenoceptors.
    Reynen PH; Martin GR; Eglen RM; MacLennan SJ
    Br J Pharmacol; 2000 Apr; 129(7):1339-46. PubMed ID: 10742289
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
    Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
    Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dual inhibitory action of trazodone on dorsal raphe serotonergic neurons through 5-HT1A receptor partial agonism and α1-adrenoceptor antagonism.
    Montalbano A; Mlinar B; Bonfiglio F; Polenzani L; Magnani M; Corradetti R
    PLoS One; 2019; 14(9):e0222855. PubMed ID: 31557210
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological characterization of [3H]-JTH-601, a novel alpha1-adrenoceptor antagonist: binding to recombinant human alpha1-adrenoceptors and human prostates.
    Takahashi M; Taniguchi T; Kanamaru H; Okada K; Muramatsu I
    Life Sci; 2000 Oct; 67(20):2443-51. PubMed ID: 11065167
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chloroethylclonidine is a partial alpha1A-adrenoceptor agonist in cells expressing recombinant alpha1-adrenoceptor subtypes.
    Villalobos-Molina R; Vázquez-Prado J; García-Sáinz JA
    Life Sci; 1997; 61(25):PL 391-5. PubMed ID: 9416771
    [TBL] [Abstract][Full Text] [Related]  

  • 80. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.